The motor protein, called kinesin-1, is responsible for transporting organelles and other cargo within cells. It does this by walking along microtubules, which are long, thin fibers that make up the cell's cytoskeleton.
Kinesin-1 takes steps along the microtubule by alternating between two conformational states. In the first state, the protein's head domain is bound to the microtubule and the tail domain is extended. In the second state, the head domain is unbound from the microtubule and the tail domain is folded.
The researchers found that the tail domain of kinesin-1 plays a critical role in the protein's ability to move along microtubules. The tail domain interacts with the microtubule surface and helps to stabilize the protein's binding to the microtubule.
This discovery could lead to new treatments for diseases that affect cell movement. For example, drugs that target the tail domain of kinesin-1 could be used to inhibit the protein's activity and prevent cells from moving. This could be beneficial in treating diseases such as cancer and neurodegenerative disorders, which are characterized by abnormal cell movement.
The researchers are continuing to study kinesin-1 and its role in cell movement. They hope that their findings will lead to new treatments for diseases that affect cell movement.
